Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462377) titled 'A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC' on March 5.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: EpiBiologics
Condition:
Epidermal Growth Factor
Epidermal Growth Factor Receptor
Epidermal Growth Factor Receptor Gene Mutation
Non Small Cell
Non Small Cell Lung
Non Small Cell Lung Cancer
Head and Neck
Head and Neck Cancer
Head and Neck Cancers
Head and Neck Squamous Cell Cancer
Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma HNSCC
NSCLC (Non...